WHO Warns of Insufficient Pipeline of Treatments and Diagnostics to Combat Antimicrobial Resistance
The World Health Organization (WHO) has raised the alarm over the shrinking pipeline of new antibacterials and diagnostics, urging greater investment in R&D to tackle the growing threat of antimicrobial resistance (AMR).
Antimicrobial Resistance | 03/10/2025 | By Dineshwori
Cipla launches HUENA, maiden non-antibiotic drug in India for recurring UTIs
With HUENA, Cipla becomes the first in India to offer Methenamine Hippurate, a non-antibiotic therapy for recurrent UTIs, strengthening its fight against AMR.
AntiMicrobial Resistance | 06/09/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy